Ahmed T, Alam K
AAPS PharmSciTech. 2025; 26(3):68.
PMID: 39984771
DOI: 10.1208/s12249-025-03065-z.
Shen L, Zhang Q, Yao Y, Huang Y, Zheng Z, Li M
Asian J Pharm Sci. 2024; 19(6):100967.
PMID: 39640060
PMC: 11617974.
DOI: 10.1016/j.ajps.2024.100967.
Hristova-Panusheva K, Xenodochidis C, Georgieva M, Krasteva N
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931344
PMC: 11206252.
DOI: 10.3390/ph17060677.
Ouyang X, Liu Y, Zheng K, Pang Z, Peng S
Asian J Pharm Sci. 2024; 19(1):100883.
PMID: 38357524
PMC: 10861844.
DOI: 10.1016/j.ajps.2023.100883.
Wang Y, Gao N, Li X, Ling G, Zhang P
Drug Deliv Transl Res. 2024; 14(7):1737-1755.
PMID: 38329709
DOI: 10.1007/s13346-023-01500-x.
Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives.
Wang H, Qiao C, Guan Q, Wei M, Li Z
Asian J Pharm Sci. 2023; 18(4):100829.
PMID: 37588992
PMC: 10425855.
DOI: 10.1016/j.ajps.2023.100829.
Synthesis and Evaluation of Alginate-Based Nanogels as Sustained Drug Carriers for Caffeine.
Suhail M, Fang C, Chiu I, Khan A, Wu Y, Lin I
ACS Omega. 2023; 8(26):23991-24002.
PMID: 37426260
PMC: 10324385.
DOI: 10.1021/acsomega.3c02699.
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis.
Dzobo K, Dandara C
Biomimetics (Basel). 2023; 8(2).
PMID: 37092398
PMC: 10123695.
DOI: 10.3390/biomimetics8020146.
Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies.
Rafik S, Vaidya J, MacRobert A, Yaghini E
J Clin Med. 2023; 12(7).
PMID: 37048731
PMC: 10095028.
DOI: 10.3390/jcm12072648.
Biomimetic nanoparticles for tumor immunotherapy.
Yu H, Wu M, Chen S, Song M, Yue Y
Front Bioeng Biotechnol. 2022; 10:989881.
PMID: 36440446
PMC: 9682960.
DOI: 10.3389/fbioe.2022.989881.
Physically stimulus-responsive nanoparticles for therapy and diagnosis.
Farjadian F, Ghasemi S, Akbarian M, Hoseini-Ghahfarokhi M, Moghoofei M, Doroudian M
Front Chem. 2022; 10:952675.
PMID: 36186605
PMC: 9515617.
DOI: 10.3389/fchem.2022.952675.
Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy.
Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J, Modarresi M
Front Bioeng Biotechnol. 2022; 10:949704.
PMID: 35992340
PMC: 9388766.
DOI: 10.3389/fbioe.2022.949704.
Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies.
Wang Y, Luo C, Zhou S, Wang X, Zhang X, Li S
Asian J Pharm Sci. 2021; 16(5):643-652.
PMID: 34849169
PMC: 8609389.
DOI: 10.1016/j.ajps.2021.02.001.
2D Nanosheets-A New Class of Therapeutic Formulations against Cancer.
Manisekaran R, Garcia-Contreras R, Rasu Chettiar A, Serrano-Diaz P, Lopez-Ayuso C, Arenas-Arrocena M
Pharmaceutics. 2021; 13(11).
PMID: 34834218
PMC: 8620729.
DOI: 10.3390/pharmaceutics13111803.
Novel Biomimetic Human TLR2-Derived Peptides for Potential Targeting of Lipoteichoic Acid: An In Silico Assessment.
Devnarain N, Waddad A, de la Torre B, Albericio F, Govender T
Biomedicines. 2021; 9(8).
PMID: 34440267
PMC: 8391229.
DOI: 10.3390/biomedicines9081063.
Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review.
Awad N, Paul V, AlSawaftah N, Ter Haar G, Allen T, Pitt W
ACS Pharmacol Transl Sci. 2021; 4(2):589-612.
PMID: 33860189
PMC: 8033618.
DOI: 10.1021/acsptsci.0c00212.
Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.
Siafaka P, Ustundag Okur N, Karantas I, Okur M, Gundogdu E
Asian J Pharm Sci. 2021; 16(1):24-46.
PMID: 33613728
PMC: 7878458.
DOI: 10.1016/j.ajps.2020.03.003.
Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer.
Wang X, Liu Y, Xu W, Jia L, Chi D, Yu J
Drug Deliv Transl Res. 2021; 11(5):2186-2197.
PMID: 33452654
DOI: 10.1007/s13346-020-00884-4.